Although states decide on vaccination schedules, the inclusion of COVID-19 shots to the national recommendation means the vaccine’s fees are waived for uninsured children when federal funds run out. That day is nearing as the COVID-19 public health emergency will end in May.
For people under 18 years old, here is the recommended COVID-19 primary series:
- 6 months to 4 years old: Moderna’s two-dose series at 0 and 4-8 weeks or Pfizer’s three-dose series at 0, 3-8 and 11-16 weeks.
- 5 to 11 years old: Moderna’s two-dose series at 0 and 4-8 weeks or Pfizer’s two-dose series at 0 and 3-8 weeks.
- 12 to 18 years old: Moderna’s two-dose series at 0 and 4-8 weeks; Pfizer’s two-dose series at 0 and 3-8 weeks; or Novavax’s two-dose series at 0 and 3-8 weeks.
The recommended COVID-19 immunization schedule for adults is Moderna’s two-dose series at 0 and 4-8 weeks, Pfizer’s two-dose series at 0 and 3-8 weeks or Novavax’s two-dose series at 0 and 3-8 weeks.
There are different recommendations for special situations, such as those who are moderately or severely immunocompromised.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
